Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202163
Status:
COMPLETED
Last Update Posted:
2016-01-13
First Post:
2005-09-13
Brief Title:
ANDRO 2002 Dehydroepiandrosterone DHEA or Testosterone Versus Placebo in Men With Sexual Dysfunction
Sponsor:
Queens University
Organization:
Queens University
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Study Comparing the Safety and Efficacy of Dehydroepiandrosterone DHEA or Testosterone Versus Placebo in Men With Sexual Dysfunction
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Androgen deficiency in the aging male is poorly understood The objective of this study will be to determine the role of testosterone and DHEA in enhancing sexual interest and sexual performance
Detailed Description:
120 men with a diagnosis of Erectile dysfunction ED will be randomized to one of three arms in the study DHEA 50 mg testosterone T 80 mg or placebo Patients will be evaluated after starting blinded medication at 30 day intervals for a total of 90 days Response will be evaluated with blood parameters physical examination including rectal examination validated questionnaires and global assessment scales
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None